Mesirow, the Chicago-based diversified financial services firm, has advised The Winsford Company on the sale of Harloff Manufacturing to Capsa Healthcare, a transaction that underscores continued consolidation activity in the medical storage and healthcare equipment sector. PR Newswire reported the deal under the headline “Mesirow Advises The Winsford Company On Its Sale Of Harloff Manufacturing To Capsa Healthcare,” marking another notable exit facilitated by Mesirow’s investment banking division.
Harloff Manufacturing, headquartered in Colorado, is a long-established producer of medical carts, storage solutions, and related equipment used across hospitals, surgical centers, and other healthcare facilities throughout North America. The company has built a reputation over several decades for durable, customizable products that serve the medication management and clinical supply chain markets, segments that have attracted growing strategic interest as healthcare systems seek to improve operational efficiency and reduce costs at the point of care.
Capsa Healthcare, the acquiring party, is a recognized provider of medication management, mobile computing, and point-of-care technology solutions for healthcare environments. The acquisition of Harloff is expected to broaden Capsa’s product portfolio and geographic reach, particularly in the physical storage and cart segment, complementing its existing technology-driven offerings. Industry analysts have noted that the deal positions Capsa more competitively against larger players in the healthcare equipment space, where scale and product breadth are increasingly decisive factors in winning hospital procurement contracts.
The Winsford Company, a private equity-oriented holding firm focused on manufacturing and industrial businesses, had owned Harloff as part of its portfolio of operationally intensive assets. The decision to divest reflects a broader trend among middle-market holding companies to monetize mature assets in sectors where strategic acquirers can offer premium valuations, particularly when the target holds a defensible niche in a growing end market such as healthcare infrastructure. Middle-market deal activity in the healthcare equipment space has remained relatively resilient even as broader mergers and acquisitions volumes faced headwinds from elevated interest rates and tighter financing conditions over the past two years, a dynamic that has reshaped how leveraged buyouts and strategic acquisitions are structured across industries.
Mesirow’s investment banking team, which focuses heavily on sell-side advisory mandates for middle-market companies, acted as exclusive financial advisor to The Winsford Company throughout the transaction process. The firm has cultivated a strong track record in healthcare-related divestitures, leveraging its sector expertise to run competitive sale processes that surface both strategic and financial acquirers. Financial terms of the Harloff transaction were not publicly disclosed.
The deal is expected to close in the near term, subject to customary regulatory reviews and closing conditions. For Capsa Healthcare, the integration of Harloff’s manufacturing capabilities and established customer relationships represents a tangible step toward building a more comprehensive product ecosystem for acute care and outpatient settings alike.